ADMA BIOLOGICS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Adma Biologics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2023.
  • Adma Biologics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$1.45M, a 123% decline year-over-year.
  • Adma Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$39M, a 136% decline from 2022.
  • Adma Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $109M, a 10.1% decline from 2021.
  • Adma Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $121M, a 15.9% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$39M -$148M -136% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $109M -$12.2M -10.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $121M -$22.8M -15.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $144M +$63.9M +79.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $80M +$37.1M +86.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $42.9M -$17.8M -29.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $60.8M +$43.9M +261% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 $16.8M +$6.44M +61.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 $10.4M +$607K +6.19% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-24
2014 $9.8M -$17.8M -64.6% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
2013 $27.6M +$8.16M +41.9% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-09
2012 $19.5M +$18.2M +1409% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-28
2011 $1.29M Jan 1, 2011 Dec 31, 2011 10-K 2013-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.